Yumi A. Warren

2.1k citations

47 papers · 1.5k indexed · h-index 25

Infectious Diseases top 2%
Clinical Biochemistry top 0.5%
Epidemiology top 10%
Public Health, Environmental and Occupational Health top 5%
Pharmacology top 5%

Co-authors: Ellie J. C. Goldstein Diane M. Citron Kerin L. Tyrrell C. Vreni Merriam Helen T. Fernandez Georg Conrads Hans‐Peter Horz Sushma Nachnani
Topics: Bacterial Identification and Susceptibility Testing (23 papers)Streptococcal Infections and Treatments (19 papers)Antimicrobial Resistance in Staphylococcus (16 papers)
Cited by: Clinical Biochemistry Molecular Medicine Applied Microbiology and Biotechnology
Journals: SHILAP Revista de lepidopterologíaClinical Infectious Diseases Journal of Clinical Microbiology
Partner nations: United States Germany

In The Last Decade

Yumi A. Warren

47 papers receiving 1.5k citations

Peers

Countries citing papers authored by Yumi A. Warren

Since Specialization

Citations

This map shows the geographic impact of Yumi A. Warren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yumi A. Warren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yumi A. Warren more than expected).

Fields of papers citing papers by Yumi A. Warren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yumi A. Warren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yumi A. Warren. The network helps show where Yumi A. Warren may publish in the future.

Co-authorship network of co-authors of Yumi A. Warren

This figure shows the co-authorship network connecting the top 25 collaborators of Yumi A. Warren. A scholar is included among the top collaborators of Yumi A. Warren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yumi A. Warren. Yumi A. Warren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fusobacteria behaving badly: Masquerading strains of strictly anaerobic Escherichia coli misidentified due to the deletion of the hemB gene 2022 ·Anaerobe ·Bradley T. Endres,Eugénie Bassères,Diane M. Citron,Kerin L. Tyrrell,Khurshida Begum,(unknown),Yumi A. Warren,(unknown),Kevin W. Garey,Ellie J. C. Goldstein	1
2	Re-assessment of phenotypic identifications of Bacteroides putredinis to Alistipes species using molecular methods 2011 ·Anaerobe ·Kerin L. Tyrrell,Yumi A. Warren,Diane M. Citron,Ellie J. C. Goldstein	20
3	Bactericidal activity of telavancin, vancomycin and metronidazole against Clostridium difficile 2010 ·Anaerobe ·Ellie J. C. Goldstein,Diane M. Citron,Kerin L. Tyrrell,Yumi A. Warren	7
4	Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria 2009 ·Journal of Antimicrobial Chemotherapy ·D. M. Citron,Yumi A. Warren,Kerin L. Tyrrell,(unknown),Ellie J. C. Goldstein	33
5	In vitro activity of azithromycin and nine comparator agents against 296 strains of oral anaerobes and 31 strains of Eikenella corrodens 2006 ·International Journal of Antimicrobial Agents ·C. Vreni Merriam,Diane M. Citron,Kerin L. Tyrrell,Yumi A. Warren,Ellie J. C. Goldstein	24
6	Comparative In Vitro Susceptibilities of 396 Unusual Anaerobic Strains to Tigecycline and Eight Other Antimicrobial Agents 2006 ·Antimicrobial Agents and Chemotherapy ·Ellie J. C. Goldstein,Diane M. Citron,C. Vreni Merriam,Yumi A. Warren,Kerin L. Tyrrell,Helen T. Fernandez	37
7	In Vitro Activities of Daptomycin, Vancomycin, and Penicillin against Clostridium difficile , C. perfringens , Finegoldia magna , and Propionibacterium acnes 2006 ·Antimicrobial Agents and Chemotherapy ·Kerin L. Tyrrell,Diane M. Citron,Yumi A. Warren,Helen T. Fernandez,C. Vreni Merriam,Ellie J. C. Goldstein	35
8	Synergistes Group Organisms of Human Origin 2006 ·Journal of Clinical Microbiology ·Hans‐Peter Horz,Diane M. Citron,Yumi A. Warren,Ellie J. C. Goldstein,Georg Conrads	54
9	In vitro activity of 11 antibiotics against 74 anaerobes isolated from pediatric intra-abdominal infections 2005 ·Anaerobe ·Ellie J. C. Goldstein,Diane M. Citron,Sagar A. Vaidya,Yumi A. Warren,Kerin L. Tyrrell,C. Vreni Merriam,Helen T. Fernandez	14
10	In vitro activities of tinidazole and metronidazole against Clostridium difficile, Prevotella bivia and Bacteroides fragilis 2005 ·Anaerobe ·(unknown),Kerin L. Tyrrell,Yumi A. Warren,Helen T. Fernandez,C. Vreni Merriam,Ellie J. C. Goldstein	23
11	Comparative In Vitro Activities of Retapamulin (SB-275833) against 141 Clinical Isolates of Propionibacterium spp., Including 117 P. acnes Isolates 2005 ·Antimicrobial Agents and Chemotherapy ·Ellie J. C. Goldstein,Diane M. Citron,C. Vreni Merriam,Yumi A. Warren,Kerin L. Tyrrell,Helen T. Fernandez	24
12	In Vitro Activities of Iodonium Salts against Oral and Dental Anaerobes 2004 ·Antimicrobial Agents and Chemotherapy ·Ellie J. C. Goldstein,Diane M. Citron,Yumi A. Warren,C. Vreni Merriam,Kerin L. Tyrrell,Helen T. Fernandez,Ukkiramapandian Radhakrishnan,Peter J. Stang,Georg Conrads	12
13	Comparative In Vitro Activities of XRP 2868, Pristinamycin, Quinupristin-Dalfopristin, Vancomycin, Daptomycin, Linezolid, Clarithromycin, Telithromycin, Clindamycin, and Ampicillin against Anaerobic Gram-Positive Species, Actinomycetes, and Lactobacilli 2004 ·Antimicrobial Agents and Chemotherapy ·Ellie J. C. Goldstein,Diane M. Citron,C. Vreni Merriam,Yumi A. Warren,Kerin L. Tyrrell,Helen T. Fernandez,A. Bryskier	29
14	Anaerobic bacteria cultured from the tongue dorsum of subjects with oral malodor 2003 ·Anaerobe ·Kerin L. Tyrrell,Diane M. Citron,Yumi A. Warren,Sushma Nachnani,Ellie J. C. Goldstein	38
15	Bacteriology of human bite wound infections 2003 ·Anaerobe ·C. Vreni Merriam,Helen T. Fernandez,Diane M. Citron,Kerin L. Tyrrell,Yumi A. Warren,Ellie J. C. Goldstein	21
16	In Vitro Activities of ABT-492, a New Fluoroquinolone, against 155 Aerobic and 171 Anaerobic Pathogens Isolated from Antral Sinus Puncture Specimens from Patients with Sinusitis 2003 ·Antimicrobial Agents and Chemotherapy ·Ellie J. C. Goldstein,Diane M. Citron,C. Vreni Merriam,Yumi A. Warren,Kerin L. Tyrrell,Helen T. Fernandez	21
17	In Vitro Activities of Telithromycin and 10 Oral Agents against Aerobic and Anaerobic Pathogens Isolated from Antral Puncture Specimens from Patients with Sinusitis 2003 ·Antimicrobial Agents and Chemotherapy ·Ellie J. C. Goldstein,Diane M. Citron,C. Vreni Merriam,Yumi A. Warren,(unknown),Helen T. Fernandez	17
18	General Microbiology and In Vitro Susceptibility of Anaerobes Isolated from Complicated Skin and Skin‐Structure Infections in Patients Enrolled in a Comparative Trial of Ertapenem Versus Piperacillin‐Tazobactam 2002 ·Clinical Infectious Diseases ·Ellie J. C. Goldstein,Diane M. Citron,C. Vreni Merriam,Yumi A. Warren,Kerin L. Tyrrell,Richard Gesser	27
19	In vitro activity of gemifloxacin compared to seven other oral antimicrobial agents against aerobic and anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis 2002 ·Diagnostic Microbiology and Infectious Disease ·Ellie J. C. Goldstein,Georg Conrads,Diane M. Citron,C. Vreni Merriam,Yumi A. Warren,Kerin L. Tyrrell	9
20	Activities of Telithromycin (HMR 3647, RU 66647) Compared to Those of Erythromycin, Azithromycin, Clarithromycin, Roxithromycin, and Other Antimicrobial Agents against Unusual Anaerobes 1999 ·Antimicrobial Agents and Chemotherapy ·Ellie J. C. Goldstein,Diane M. Citron,C. Vreni Merriam,Yumi A. Warren,Kerin L. Tyrrell	36

About Yumi A. Warren

Yumi A. Warren is a scholar working on Clinical Biochemistry, Virology and Molecular Medicine, having authored 47 papers that have together received 1.5k indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (23 papers), Streptococcal Infections and Treatments (19 papers) and Antimicrobial Resistance in Staphylococcus (16 papers). The work is most often cited by research in Clinical Biochemistry (475 citations), Molecular Medicine (306 citations) and Applied Microbiology and Biotechnology (110 citations). Yumi A. Warren has collaborated with scholars based in United States and Germany. Frequent co-authors include Ellie J. C. Goldstein, Diane M. Citron, Kerin L. Tyrrell, C. Vreni Merriam, Helen T. Fernandez, Georg Conrads, Hans‐Peter Horz, Sushma Nachnani, Ellie J. C. Goldstein and D. M. Citron. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Journal of Clinical Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact